IIC
IMGN

Integrated Investment Consultants’s Immunogen Inc IMGN Stock Holding History

Integrated Investment Consultants’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-588
Closed -$6K – 743
2018
Q1 		$6K Buy
+588
New +$5.81K ﹤0.01% 719
2017
Q3 		$4K Hold
588
– – ﹤0.01% 579
2017
Q2 		$4K Hold
588
– – ﹤0.01% 553
2017
Q1 		$2K Hold
588
– – ﹤0.01% 567
2016
Q4 		$1K Hold
588
– – ﹤0.01% 575
2016
Q3 		$1K Hold
588
– – ﹤0.01% 585
2016
Q2 		$2K Hold
588
– – ﹤0.01% 585
2016
Q1 		$5K Buy
+588
New +$4.97K ﹤0.01% 557

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Integrated Investment Consultants's IMGN Position: Q2 2018 in Review

Integrated Investment Consultants sold out of Immunogen Inc (IMGN) in Q2 2018, closing a stake of 588 shares — an estimated $6K sold.

Integrated Investment Consultants first reported a position in IMGN in Q1 2016 and held it in 8 quarters. The position peaked at $6K in Q1 2018. 198 funds tracked by Wall St. Rank hold IMGN as of Q2 2018.

  • Integrated Investment Consultants reported no remaining Immunogen Inc position as of Q2 2018 after selling out during the quarter.
  • Integrated Investment Consultants sold 588 Immunogen Inc shares in Q2 2018, an estimated $6K.
  • Integrated Investment Consultants first reported a position in Immunogen Inc in Q1 2016 and held it in 8 quarters.
  • Integrated Investment Consultants's Immunogen Inc position peaked at $6K in Q1 2018.
  • 198 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2018.

Based on Integrated Investment Consultants's 13F filing for Q2 2018, filed 1 Aug 2018.